Deborah Downs

1.0k total citations
20 papers, 837 citations indexed

About

Deborah Downs is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Deborah Downs has authored 20 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Deborah Downs's work include Enzyme Catalysis and Immobilization (7 papers), Alzheimer's disease research and treatments (5 papers) and Pancreatic function and diabetes (5 papers). Deborah Downs is often cited by papers focused on Enzyme Catalysis and Immobilization (7 papers), Alzheimer's disease research and treatments (5 papers) and Pancreatic function and diabetes (5 papers). Deborah Downs collaborates with scholars based in United States, China and Switzerland. Deborah Downs's co-authors include Jordan Tang, Mark R. Leary, John B. Nezlek, Arun K. Ghosh, et al, Wan‐Pin Chang, Chi‐Sun Wang, Jeffrey Martin, Kenneth W. Jackson and Xiangping Huang and has published in prestigious journals such as Journal of Personality and Social Psychology, Biochemistry and The FASEB Journal.

In The Last Decade

Deborah Downs

20 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Downs United States 15 255 202 152 128 123 20 837
Claes Andersson Sweden 25 636 2.5× 263 1.3× 47 0.3× 94 0.7× 135 1.1× 114 1.9k
David Singer United States 24 488 1.9× 300 1.5× 50 0.3× 26 0.2× 61 0.5× 65 1.8k
Naoki Fukui Japan 21 240 0.9× 75 0.4× 78 0.5× 33 0.3× 18 0.1× 122 1.7k
Anna Cheung Hong Kong 20 650 2.5× 91 0.5× 297 2.0× 42 0.3× 273 2.2× 28 1.6k
John A. Bachman United States 20 655 2.6× 78 0.4× 371 2.4× 81 0.6× 105 0.9× 31 1.8k
Jukka Leppänen Finland 16 263 1.0× 69 0.3× 107 0.7× 35 0.3× 14 0.1× 27 897
Christine M. Roberts United States 15 443 1.7× 311 1.5× 98 0.6× 42 0.3× 11 0.1× 28 1.0k
Maria Olsson Sweden 20 254 1.0× 449 2.2× 85 0.6× 62 0.5× 108 0.9× 43 1.1k
Sadia Saleem Pakistan 18 161 0.6× 180 0.9× 82 0.5× 11 0.1× 60 0.5× 99 1.1k
Musaad A. Alshammari Saudi Arabia 23 406 1.6× 131 0.6× 68 0.4× 17 0.1× 37 0.3× 55 1.2k

Countries citing papers authored by Deborah Downs

Since Specialization
Citations

This map shows the geographic impact of Deborah Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Downs more than expected).

Fields of papers citing papers by Deborah Downs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Downs. The network helps show where Deborah Downs may publish in the future.

Co-authorship network of co-authors of Deborah Downs

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Downs. A scholar is included among the top collaborators of Deborah Downs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Downs. Deborah Downs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ghosh, Arun K., Margherita Brindisi, Emma K. Lendy, et al.. (2019). Highly Selective and Potent Human β‐Secretase 2 (BACE2) Inhibitors against Type 2 Diabetes: Design, Synthesis, X‐ray Structure and Structure–Activity Relationship Studies. ChemMedChem. 14(5). 545–560. 16 indexed citations
3.
Ghosh, Arun K., Bhavanam Sekhara Reddy, Kalapala Venkateswara Rao, et al.. (2016). Design of potent and highly selective inhibitors for human β-secretase 2 (memapsin 1), a target for type 2 diabetes. Chemical Science. 7(5). 3117–3122. 14 indexed citations
4.
Wu, Hao, Deborah Downs, Koena Ghosh, et al.. (2013). Candida albicans secreted aspartic proteases 4–6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism. The FASEB Journal. 27(6). 2132–2144. 56 indexed citations
5.
Chang, Wan‐Pin, Xiangping Huang, Deborah Downs, et al.. (2010). β‐Secretase inhibitor GRL‐8234 rescues age‐related cognitive decline in APP transgenic mice. The FASEB Journal. 25(2). 775–784. 92 indexed citations
6.
Chang, Wan‐Pin, et al.. (2007). Amyloid‐beta reduction by memapsin 2 (beta‐secretase) immunization. The FASEB Journal. 21(12). 3184–3196. 34 indexed citations
7.
Chang, Wan‐Pin, Gerald Koelsch, Stephen T.C. Wong, et al.. (2004). In vivo inhibition of Aβ production by memapsin 2 (β‐secretase) inhibitors. Journal of Neurochemistry. 89(6). 1409–1416. 74 indexed citations
8.
Wang, Chi‐Sun, Azar Dashti, & Deborah Downs. (2003). Bile Salt-Activated Lipase. Humana Press eBooks. 109. 71–80. 15 indexed citations
9.
Downs, Deborah, Shili Wu, Azar Dashti, et al.. (2002). Enzymic properties of recombinant BACE2. European Journal of Biochemistry. 269(22). 5668–5677. 12 indexed citations
10.
Terzyan, S., et al.. (2000). Crystal structure of the catalytic domain of human bile salt activated lipase. Protein Science. 9(9). 1783–1790. 53 indexed citations
11.
Jackson, Kenneth W., et al.. (1998). Mass Spectrometric Characterization and Glycosylation Profile of Bovine Pancreatic Bile Salt-Activated Lipase. Protein Expression and Purification. 12(2). 259–268. 2 indexed citations
12.
Downs, Deborah, et al.. (1996). Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1302(3). 224–230. 19 indexed citations
13.
14.
Leary, Mark R., et al.. (1994). Self-presentation in everyday interactions: Effects of target familiarity and gender composition.. Journal of Personality and Social Psychology. 67(4). 664–673. 123 indexed citations
15.
Leary, Mark R., et al.. (1994). Self-presentation in everyday interactions: Effects of target familiarity and gender composition.. Journal of Personality and Social Psychology. 67(4). 664–673. 132 indexed citations
16.
Baba, Tadashi, et al.. (1991). Structure of human milk bile salt activated lipase. Biochemistry. 30(2). 500–510. 86 indexed citations
17.
Wang, Chi‐Sun, et al.. (1990). Acylglycerol reactivity and reaction mechanism of bovine milk lipoprotein lipase. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1043(2). 143–148. 4 indexed citations
18.
Hartsuck, Jean A., et al.. (1988). Kinetics of acylglycerol sequential hydrolysis by human milk bile salt activated lipase and effect of taurocholate as fatty acid acceptor. Biochemistry. 27(13). 4834–4840. 35 indexed citations
19.
Alaupovic, P., Chi‐Sun Wang, Walter J. McConathy, D Weiser, & Deborah Downs. (1986). Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: The identification of lipoprotein B as the main lipoprotein degradation product. Archives of Biochemistry and Biophysics. 244(1). 226–237. 27 indexed citations
20.
Blackett, Piers R., Eugen Koren, Rebecca Blackstock, Deborah Downs, & Chi‐Sun Wang. (1984). Hyperlipidemia in acute lymphoblastic leukemia.. PubMed. 14(2). 123–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claes Andersson Breakdown of academic impact, for papers by David Singer Breakdown of academic impact, for papers by Naoki Fukui Breakdown of academic impact, for papers by Anna Cheung Breakdown of academic impact, for papers by John A. Bachman Breakdown of academic impact, for papers by Jukka Leppänen Breakdown of academic impact, for papers by Christine M. Roberts Breakdown of academic impact, for papers by Maria Olsson Breakdown of academic impact, for papers by Sadia Saleem Breakdown of academic impact, for papers by Musaad A. Alshammari
Rankless by CCL
2026